Corporate Facts
| HEADQUARTERS | 531 South Spring Street Burlington, North Carolina 27215 |
| TICKER SYMBOL | LH |
| NUMBER OF EMPLOYEES | More than 67,000 worldwide |
| ANNUAL REVENUE | $12.2 Billion (2023) |
| CHIEF EXECUTIVE OFFICER | Adam H. Schechter |
| PATIENT ACCESS POINTS | Labcorp provides patient access points strategically and conveniently located throughout the United States, including nearly 2,000 PSCs and more than 6,000 in-office phlebotomists located in customer offices and facilities. |
| LABCORP SPECIALTY TESTING | Labcorp is an industry leader in gene-based and esoteric testing and provides a range of frequently requested and specialty testing services, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women’s health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs and kidney stone prevention. |
| OUR BUSINESS | Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in over 100 countries, worked on over 84% of the new drugs approved by the FDA in 2023 and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH. |
| CONTACT PERSON | Kimbrel Arculeo 336-436-8263 media@labcorp.com |